Allopurinol Proves Noninferior to Febuxostat for Gout Relief Allopurinol Proves Noninferior to Febuxostat for Gout Relief

A randomized, treat-to-target trial showed that the two urate-lowering therapies were comparably effective and safe at doses titrated to target, even among people with stage 3 chronic kidney disease.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news